Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Processa Pharmaceuticals Inc (NASDAQ: PCSA) closed at $0.32 down -7.09% from its previous closing price of $0.34. In other words, the price has decreased by -$7.09 from its previous closing price. On the day, 1.42 million shares were traded. PCSA stock price reached its highest trading level at $0.34 during the session, while it also had its lowest trading level at $0.3127.
Ratios:
For a deeper understanding of Processa Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.45 and its Current Ratio is at 3.45. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 25, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 27 ’25 when Yorke Justin W bought 12,400 shares for $0.80 per share. The transaction valued at 9,889 led to the insider holds 12,400 shares of the business.
Ng George K bought 87,200 shares of PCSA for $69,542 on Jan 27 ’25. The Chief Executive Officer now owns 87,200 shares after completing the transaction at $0.80 per share. On Jan 27 ’25, another insider, Young David, who serves as the Pres. Research & Development of the company, bought 124,500 shares for $0.80 each. As a result, the insider paid 99,289 and bolstered with 205,405 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCSA now has a Market Capitalization of 17632380 and an Enterprise Value of 8994260.
Stock Price History:
The Beta on a monthly basis for PCSA is 1.08, which has changed by -0.6909091 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, PCSA has reached a high of $1.50, while it has fallen to a 52-week low of $0.15. The 50-Day Moving Average of the stock is 16.63%, while the 200-Day Moving Average is calculated to be -1.52%.
Shares Statistics:
For the past three months, PCSA has traded an average of 10.57M shares per day and 6554750 over the past ten days. A total of 50.35M shares are outstanding, with a floating share count of 43.77M. Insiders hold about 13.07% of the company’s shares, while institutions hold 0.74% stake in the company. Shares short for PCSA as of 1760486400 were 13756678 with a Short Ratio of 1.30, compared to 1757894400 on 909292. Therefore, it implies a Short% of Shares Outstanding of 13756678 and a Short% of Float of 24.91.
Earnings Estimates
The company has 1.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.43 and -$0.43 for the fiscal current year, implying an average EPS of -$0.43. EPS for the following year is -$0.15, with 1.0 analysts recommending between -$0.15 and -$0.15.
